American Headache Society Recommends CGRP-Targeting Therapies as a First-Line Treatment
March 11, 2024
National Headache Foundation supports the American Headache Society (AHS) efforts on behalf of patients and caregivers. With advocacy efforts from the migraine community, favorable momentum continues with 45% of commercial health plans/PBMs aligned covering CGRPs for prevention with no step edits. We are expecting this to increase to 60% over the next few months.
To hear how the AHS strives to improve the lives of people impacted by migraine and other headache disorders.